«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

26卷

期数:

2020年03期

页码:

238-243

栏目:

临床医学

出版日期:

2020-06-10

文章信息/Info

Title:

Expression and clinical significance of ARL4C in testicular germ cell tumors

文章编号:

1006-8147(2020)03-0238-06

作者:

彭华红; 肖龙飞; 王林; 陈赛鹏; 王嘉南; 杨阔

（天津医科大学第二医院泌尿外科，天津 300211）

Author(s):

PENG Hua-hong; XIAO Long-fei; WANG Lin; CHEN Sai-peng; WANG Jia-nan; YANG Kuo

（Department of Tianjin Institute of Urology，The Second Hospital, Tianjin Medical University，Tianjin 300211，China）

关键词:

睾丸生殖细胞肿瘤; ARL4C; DIRAS1; GEPIA数据库

Keywords:

testicular germ cell tumor; ARL4C; DIRAS1; GEPIA database

分类号:

R697+.22

DOI:

-

文献标志码:

A

摘要:

目的：探讨ADP-核糖基化因子-4C（ARL4C）在睾丸生殖细胞肿瘤（TGCT）中的表达及其临床意义。方法：收集GEPIA数据库及天津医科大学第二医院2015-2019年睾丸生殖细胞肿瘤病人临床及病理信息，探索ARL4C在睾丸生殖细胞肿瘤中的表达情况及其对预后的影响，免疫组化、RT-qPCR及Western验证，通过STRING数据库寻找其可能的作用机制。结果：与正常组织相比，ARL4C在胆管癌、多形性胶质母细胞瘤、肾透明细胞癌、急性髓系白血病、肺鳞状细胞癌、卵巢浆液性囊腺癌、胰腺癌、嗜铬细胞瘤和副神经节瘤、胃腺癌、睾丸生殖细胞肿瘤、胸腺瘤、子宫内膜癌等多种恶性肿瘤中均呈现高表达状态（均P＜0.05），在睾丸生殖细胞肿瘤中生存分析显示高表达ARL4C的患者生存时间减少（P＜0.05），GEPIA数据库提示ARL4C与DIRAS1有相互作用，相关系数为0.45（P＜0.05）。免疫组化验证DIRAS1在睾丸生殖细胞肿瘤中呈现低表达状态。结论：ARL4C在睾丸生殖细胞肿瘤中高表达，且其高表达与预后不良相关。

Abstract:

Objective: To investigate the expression and clinical significance of ADP-ribosylation factor-4C (ARL4C) in testicular germ cell tumors (TGCT). Methods: The clinical and pathological information of patients with testicular germ cell tumors in GEPIA database and Tianjin Medical University Second Hospital from 2015 to 2019 were collected to explore the expression of ARL4C in testicular germ cell tumors and its impact on prognosis. The expression was validated by immunohistochemistry, RT-qPCR and Western bolt. The possible mechanism was found by STRING database. Results: Compared with normal tissues, ARL4C showed high expression status in cholangiocarcinoma, glioblastoma multiforme, renal clear cell carcinoma, acute myeloid leukemia, lung squamous cell carcinoma, ovarian serous cystadenocarcinoma, pancreatic cancer, chromaffin cellular and paraganglioma, gastric adenocarcinoma, testicular germ cell tumor, thymoma, endometrial cancer and other malignant tumors(all P＜0.05). Survival analysis in testicular germ cell tumors showed that patients with high expression of ARL4C had decreased survival time (P＜0.05). The GEPIA database suggested that ARL4C interacted with DIRAS1 and correlation coefficient was 0.45(P＜0.05). Immunohistochemistry confirmed that DIRAS1 showed a low expression status in testicular germ cell tumors. Conclusion: ARL4C is highly expressed in testicular germ cell tumors, and its high expression is associated with poor prognosis.

参考文献/References:

[1] Cheng L, Albers P, Berney D M, et al. Testicular cancer[J]. Nat Rev Dis Primers, 2018, 4(1):29
[2] Daugaard G, Gundgaard M G, Mortensen M S, et al. Surveillance for stage I nonseminoma testicular cancer:outcomes and long-term follow-up in a population-based cohort[J]. J Clin Oncol, 2014, 32(34):3817
[3] Hofmann I, Thompson A, Sanderson C M, et al. The Arl4 family of small G proteins can recruit the cytohesin Arf6 exchange factors to the plasma membrane[J]. Curr Biol, 2007, 17(8):711
[4] Fujii S, Matsumoto S, Nojima S, et al. Arl4c expression in colorectal and lung cancers promotes tumorigenesis and May represent a novel therapeutic target[J]. Oncogene, 2015, 34(37):4834
[5] Bergom C, Hauser A D, Rymaszewski A, et al. The tumor-suppressive small GTPase DiRas1 binds the noncanonical guanine nucleotide exchange factor SmgGDS and antagonizes SmgGDS interactions with oncogenic small GTPases[J]. J Biol Chem, 2016, 291(12):6534
[6] Ellis C A, Vos M D, Howell H, et al. Rig is a novel Ras-related protein and potential neural tumor suppressor[J]. Proc Natl Acad Sci U S A, 2002,99(15):9876
[7] Zhu Y H, Fu L, Chen L L, et al. Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma[J]. Cancer Res, 2013, 73(7):2298
[8] Vasdev N, Moon A, Thorpe A C, et al. Classification, epidemiology and therapies for testicular germ cell tumours[J]. Int J Dev Biol, 2013, 57(2/4):133
[9] Almstrup K, Nielsen J E, Mlynarska O, et al. Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells[J]. Br J Cancer, 2010, 103(8):1269
[10] Berney D M, Looijenga L H, Idrees M, et al. Germ cell neoplasia in situ(GCNIS): evolution of the current nomenclature for testicular pre-invasive germ cell malignancy[J]. Histopathology, 2016, 69(1):7
[11] Gillingham A K, Munro S.The small G proteins of the Arf family and their regulators[J]. Annu Rev Cell Dev Biol, 2007, 23(1):579
[12] Bhamidipati A, Lewis S A, Cowan N J. ADP ribosylation factor-like protein 2(Arl2)regulates the interaction of tubulin-folding cofactor D with native tubulin[J]. J Cell Biol, 2000, 149(5):1087
[13] Lu L, Tai G, Hong W. Autoantigen Golgin-97, an effector of Arl1 GTPase, participates in traffic from the endosome to the trans-Golgi network [J]. Mol Biol Cell, 2004, 15(10):4426
[14] Lin C Y, Huang P H, Liao W L, et al. ARL4,an ARF-like protein that is developmentally regulated and localized to nuclei and nucleoli[J]. J Biol Chem, 2000, 275(48):37815
[15] Wei S M, Xie C G, Abe Y, et al. ADP-ribosylation factor like 7(ARL7)interacts with alpha-tubulin and modulates intracellular vesicular transport[J]. Biochem Biophys Res Commun, 2009, 384(3):352
[16] Matsumoto S, Fujii S, Sato A, et al. A combination of Wnt and growth factor signaling induces Arl4c expression to form epithelial tubular structures[J]. EMBO J, 2014, 33(7):702
[17] Hu Q, Masuda T, Sato K, et al. Identification of ARL4C as a peritoneal dissemination-associated gene and its clinical significance in gastric cancer[J]. Ann Surg Oncol, 2018, 25(3):745

相似文献/References:

备注/Memo

备注/Memo:

作者简介 彭华红（1993-），女，硕士在读，研究方向：泌尿外科；通信作者：杨阔，E-mail：ykuoster@126.com。

常用功能

更新日期/Last Update: 2020-06-13